Inventor · disambiguated record
Hrissanthi Ikonomidou
Also filed as: IKONOMIDOU HRISSANTHI
7 granted patents·48 citations·filing 1999–2007
80Inventor score
Top patents by PatentIndex Score
7 records- 0174US7410962B2Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2007·Granted Aug 12, 2008·2 cites·11 claims
- 0273US7427611B2Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2006·Granted Sep 23, 2008·2 cites·11 claims
- 0372US6797692B1Use of glutamate antagonists for the treatment of cancerFiled 1999·Granted Sep 28, 2004·38 cites·9 claims
- 0471US7262184B2Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2004·Granted Aug 28, 2007·2 cites·14 claims
- 0562US7247610B2Use of glutamate antagonists for the treatment of cancerIKONOMIDOU HRISSANTHI·Filed 2004·Granted Jul 24, 2007·4 cites·15 claims
- 0653US7452875B2Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2007·Granted Nov 18, 2008·0 cites·11 claims
- 0742US7232813B2Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neuro-degenerative disordersSOLVAY PHARM BV·Filed 2005·Granted Jun 19, 2007·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Hrissanthi Ikonomidou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →